SLC25A25 and breast carcinoma: Moreover, the mutation analysis of SLC25 family in tumor cell lines revealed that the mutation rate of SLC25A25 was the highest in breast cancer, suggesting that SLC25A25 was more apt to mutate in the environment of breast tissue.